Correlation Between Novo Nordisk and Enzolytics
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Enzolytics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Enzolytics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Enzolytics, you can compare the effects of market volatilities on Novo Nordisk and Enzolytics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Enzolytics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Enzolytics.
Diversification Opportunities for Novo Nordisk and Enzolytics
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Novo and Enzolytics is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Enzolytics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzolytics and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Enzolytics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzolytics has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Enzolytics go up and down completely randomly.
Pair Corralation between Novo Nordisk and Enzolytics
Assuming the 90 days horizon Novo Nordisk AS is expected to generate 0.28 times more return on investment than Enzolytics. However, Novo Nordisk AS is 3.59 times less risky than Enzolytics. It trades about 0.06 of its potential returns per unit of risk. Enzolytics is currently generating about -0.05 per unit of risk. If you would invest 6,192 in Novo Nordisk AS on August 26, 2024 and sell it today you would earn a total of 4,402 from holding Novo Nordisk AS or generate 71.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. Enzolytics
Performance |
| Timeline |
| Novo Nordisk AS |
| Enzolytics |
Novo Nordisk and Enzolytics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and Enzolytics
The main advantage of trading using opposite Novo Nordisk and Enzolytics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Enzolytics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzolytics will offset losses from the drop in Enzolytics' long position.The idea behind Novo Nordisk AS and Enzolytics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |